Please use this identifier to cite or link to this item:
https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6030Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | VAMSHI KRISHNA | - |
| dc.date.accessioned | 2026-02-26T05:42:10Z | - |
| dc.date.available | 2026-02-26T05:42:10Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.uri | https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6030 | - |
| dc.description.abstract | The metabolic syndrome is a constellation of central obesity, Hypertriglyceridemia, low HDL cholesterol, hyperglycemia, and hypertension. Elevated serum ferritin levels independently predicted incident type 2 diabetes in prospective studies in apparently healthy men and women. In cross-sectional studies, elevated ferritin levels have been associated with hypertension, dyslipidemia, elevated fasting insulin and blood glucose and central adiposity. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BLDE (DU) | en_US |
| dc.subject | metabolic syndrome, ferritin | en_US |
| dc.title | STUDY OF LEVELS OF SERUM FERRITIN IN PATIENTS WITH METABOLIC SYNDROME | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Department of General Medicine | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Dr. M. VAMSHI KRISHNA 2015.pdf | 964.17 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.